Sanofi S.A is founded in 1970 and is headquartered in Paris, France. It is a developer, manufacturer, and marketer of health care products. The company operates in three business segments, namely Pharmaceuticals, Human Vaccines, and Animal Health. Its subsidiary Sanofi-Aventis, U.S. manufactures mepenzolate- and bupropion hydrobromide-based products. The company employs more than 1,00,000 people. The company has its presence in Europe, Africa, Asia, Australia, New Zealand, Europe, and South & Central America.
In April 2013, Sanofi opened a new logistics hub in Africa. It helped the company to increase the distribution of its medicines in Africa. Sanofi signed three collaboration agreements with Morocco government, decided to improve the care of type 1 diabetes patients. The new logistics hub increased the sales of company’s bromine-based Aplenzin tablet.
Download PDF for More Information
http://www.micromarketmonitor.com/contact/4696118874-download_pdf_brochure.html
In addition to this, Sanofi S.A. (France) is one of the leading pharmaceutical manufacturers in Europe. Aplenzin (buproplon hydrobromide) and Cantil are the two brominated medicines manufactured by Sanofi. Aplenzin tablet is an aminoketone antidepressant. It is used to treat major depressive disorder and seasonal affective disorder in adults. Cantil tablets contain a specific amount of mepenzolate bromide USP. Cantil tablets are used to reduce gastric acid and pepsin secretion. It is used as an adjunctive therapy for treating peptic ulcer.
Israel Chemical Ltd. is an Israel-based company, founded in 1968, that manufactures and sells fertilizers and specialty chemicals. Israel Chemicals operates in three business segments, namely Fertilizers, Industrial, and Performance products. The company along with its subsidiaries manufactures bromine and bromine-based compounds or products. The company employs more than 12,280 people and is headquartered at Tel Aviv, Israel. The company operates globally through its subsidiaries, with a strong presence in North America, South America, Europe, and Australia.
Speak to Analyst
http://www.micromarketmonitor.com/contact/4696118874-speak_to_analyst.html
In 2012, ICL consolidated its flame retardant products portfolio with IMCD Group B.V. (U.K. & Ireland). IMCD's strong presence in main markets helped ICL to promote its products in the U.K. and Ireland.
In addition to this, in December 2011, ICL bought 50% stake of Tetrabrom Technologies (Israel). Tetrabrom is the joint venture of ICL and Chemtura Corp (U.S.). This acquisition is expected to strengthen the former’s revenues from bromine.
